Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Fig. 9 | Journal of Translational Medicine

Fig. 9

From: Discrimination of cirrhotic nodules, dysplastic lesions and hepatocellular carcinoma by their vibrational signature

Fig. 9

Discrimination between cirrhosis, dysplastic lesions and hepatocellular carcinoma using quantifiable spectral markers. Seven patients exhibiting benign or dysplastic nodules were investigated by FTIR microspectroscopy using a FTIR microscope equipped with an internal infrared source. For each patient, acquisitions were performed on 5 maps with about 200 spectra per map. a Boxplots of ratio calculated by two areas (1050–1010 cm−1/1180–950 cm−1), baseline of 1180–950 cm−1. b Boxplots of ratio calculated by two areas (1280–1200 cm−1/1180–950 cm−1), baseline of 1360–950 cm−1. c Boxplots of ratio calculated by two main peak areas (1410–1380 cm−1/1470–1430 cm−1), baseline of 1480–1360 cm−1. Statistical analysis was performed on each individual patient with paired t test (*p < 0.05). C cirrhosis, HG high grade dysplastic nodule, LG low grade dysplastic nodule, eHCC early hepatocellular carcinoma, P patient

Back to article page